Arij Faksh

Arij Faksh

Auto-generated profile, based on publicly available information

Arij Faksh

Scripps Perinatology, Scripps Clinic Medical Group, La Jolla, CA, United States

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2023 in JMIR Formative Research
Verified
Journal Article
Open access
TAToluwalase Ajayi
Toluwalase Ajayi
JPJeff Pawelek
Jeff Pawelek
HBHansa Bhargava
Hansa Bhargava
AFArij Faksh
Arij Faksh
JRJennifer Radin
Jennifer Radin
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Maternal health outcomes have been under-researched due to pregnant people being underrepresented or excluded from studies based on their status as a vulnerable population. Medication use, safety, dosing, and efficacy have been particularly understudied in pregnant people, even though it has been shown up to 95% of pregnant people take medications. Utilization of medications and prenatal vitamins across under-represented pregnant populations is not well understood, particulary for communities that are underrepresented in biomedical research (UBR). Objective: We aimed to characterize and compare the use of prenatal vitamins, and commonly used over the counter and prescription medications, among pregnant people self-identifying as Black versus non-Black and those living in rural versus urban regions in the United States. Methods: We conducted a prospective, decentralized study of 4,130 pregnant study participants who answered survey questionnaires using a mobile research app. All pregnant people living in the U.S. comfortable with reading and writing in English were eligible. The study was conducted in a decentralized fashion with the use of a study app to facilitate enrollment using an eConsent and self-reported data collection. Results: Among the study population, there was significantly different utilization of prenatal vitamins, antiemetics, antidepressants, and pain medication across different UBR sub-populations. Black participants reported significantly lower frequencies of prenatal vitamin use compared to non-Black participants (p<0.0001). The frequency of participants who were currently receiving treatment for anxiety and depression also differed by both racial and rural/urban sub-groups. There was significantly lower use of antidepressants (p=0.002) and antiemetics (p=0.02) among Black compared to non-Black participants. Conclusions: A prospective decentralized study demonstrated lower use of prenatal vitamins among Black, non-White, and rural pregnant participants and lower use of anti-emetics among Black pregnant participants. Additional research dedicated to identifying how and why these utilization disparities exist can help improve maternal health outcomes, specifically for diverse communities. Clinical Trial: NCT03085875

22 May 2025 in JMIR Mental Health
Verified
Journal Article
Open access
GMGiulia Milan
Giulia Milan
VLVictoria Lee
Victoria Lee
MGMatteo Gadaleta
Matteo Gadaleta
LALauren Ariniello
Lauren Ariniello
AFArij Faksh
Arij Faksh
TAToluwalase Ajayi
Toluwalase Ajayi
Background: Mental health disorders such as anxiety and depression are common among individuals of childbearing age. Such disorders can affect pregnancy and postpartum well-being. This study aims to study the impact of prenatal mental health on the pregnancy journey and highlights the use of mobile health technologies such as PowerMom for symptom tracking and screening. Objectives: We collected data in a decentralized digital trial using the PowerMom platform to investigate the impact of maternal mental health throughout pregnancy. The goal was to understand how anxiety and depression influence pregnancy-related symptoms, pregnancy outcomes, and postpartum well-being. Methods: Survey data were collected via PowerMom, a bilingual mobile research platform that integrates patient-reported outcomes, wearable data, and electronic health records. Participants were divided into 2 cohorts: those who reported receiving treatment for anxiety or depression during pregnancy (n=571) and those who reported not receiving treatment (n=1505). We compared self-reported symptoms, prepregnancy conditions, complications from past pregnancies, delivery outcomes, and postpartum mental health between cohorts, using the Fisher exact test and the Kruskal-Wallis test for statistical analysis. Results: Participants receiving treatment for anxiety or depression reported higher instances of physical symptoms than those untreated, with significant differences for 13 symptoms including fatigue (80.2% vs 65.4%; adjusted P<.001), nausea and vomiting (69.7% vs 52.7%; adjusted P<.001), and stomach cramping and abdominal pain (64.0% vs 50.4%; adjusted P<.001). Participants receiving treatment also had a higher prevalence of several conditions prior to pregnancy than those not receiving treatment, with significant differences noted in 4 out of 10 conditions: endometriosis (14.0% vs 8.8%; adjusted P=.007), hypertension (10.9% vs 3.9%; adjusted P<.001), eating disorder (7.7% vs 3.1%; adjusted P<.001), and heart disease (2.8% vs 0.5%; adjusted P<.001). Participants receiving treatment also reported a higher prevalence of complications in past pregnancies than those not receiving treatment, with significant differences noted in 2 out of 7 complications: high blood pressure (9.9% vs 5.8%; adjusted P=.016) and preeclampsia (9.2% vs 5.5%; adjusted P=.021). No significant differences were observed in mode of delivery, epidural use, stillbirth, and miscarriage rates between the 2 cohorts. Postpartum, treated participants reported significantly higher mental health composite scores, indicating more severe mental health symptoms. A higher percentage of treated participants were at high risk for having perinatal mood disorder (38/83, 45.8%) than untreated participants (36/196, 18.4%; P<.001). Conclusions: The PowerMom platform demonstrated its value in facilitating remote, scalable data collection for maternal mental health research. Pregnant individuals reporting treatment for anxiety or depression experienced more physical symptoms and worse postpartum mental health outcomes than untreated individuals. These findings underscore the potential for mobile health technologies to support future interventional studies aimed at improving maternal mental health outcomes during pregnancy.

17 July 2023 in JMIR Preprints
Verified
Preprint
Open access
TAToluwalase Ajayi
Toluwalase Ajayi
JPJeff Pawelek
Jeff Pawelek
HBHansa Bhargava
Hansa Bhargava
AFArij Faksh
Arij Faksh
JRJennifer Radin
Jennifer Radin
BACKGROUND Maternal health outcomes have been underresearched due to people who are pregnant being underrepresented or excluded from studies based on their status as a vulnerable study population. Based on the available evidence, Black people who are pregnant have dramatically higher maternal morbidity and mortality rates compared to other racial and ethnic groups. However, insights into prenatal care—including the use of medications, immunizations, and prenatal vitamins—are not well understood for pregnant populations, particularly those that are underrepresented in biomedical research. Medication use has been particularly understudied in people who are pregnant; even though it has been shown that up to 95% of people who are pregnant take at least 1 or more medications. Understanding gaps in use could help identify ways to reduce maternal disparities and optimize maternal health outcomes. OBJECTIVE We aimed to characterize and compare the use of prenatal vitamins, immunizations, and commonly used over-the-counter and prescription medications among people who are pregnant, those self-identifying as Black versus non-Black, and those living in rural versus urban regions in the United States. METHODS We conducted a prospective, decentralized study of 4130 pregnant study participants who answered survey questionnaires using a mobile research app that was only available on iOS (Apple Inc) devices. All people who were pregnant, living in the United States, and comfortable with reading and writing in English were eligible. The study was conducted in a decentralized fashion with the use of a research app to facilitate enrollment using an eConsent and self-reported data collection. RESULTS Within the study population, the use of prenatal vitamins, antiemetics, antidepressants, and pain medication varied significantly among different subpopulations underrepresented in biomedical research. Black participants reported significantly lower frequencies of prenatal vitamin use compared to non-Black participants (P<.001). The frequency of participants who were currently receiving treatment for anxiety and depression was also lower among Black and rural groups compared to their non-Black and urban counterparts, respectively. There was significantly lower use of antidepressants (P=.002) and antiemetics (P=.02) among Black compared to non-Black participants. While prenatal vitamin use was lower among participants in rural areas, the difference between rural and urban groups did not reach statistical significance (P=.08). There were no significant differences in vaccine uptake for influenza or tetanus-diphtheria-pertussis (TDaP) across race, ethnicity, rural, or urban status. CONCLUSIONS A prospective, decentralized app-based study demonstrated significantly lower use of prenatal vitamins, antiemetics, and antidepressants among Black pregnant participants. Additionally, significantly fewer Black and rural participants reported receiving treatment for anxiety and depression during pregnancy. Future research dedicated to identifying the root mechanisms of these differences can help improve maternal health outcomes, specifically for diverse communities.